Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor

Publication date: Available online 7 May 2020Source: Neurochemistry InternationalAuthor(s): Mahmoud I. Youssef, Yiting Zhou, Ibrahim H. Eissa, Yanhui Wang, Jing Zhang, Lei Jiang, Weiwei Hu, Jianhua Qi, Zhong Chen
Source: Neurochemistry International - Category: Neuroscience Source Type: research